1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Overlaps and divergences between tauopathies and synucleinopathies : a duet of neurodegeneration
(
- Contribution to journal › Scientific review
- 2023
-
Mark
α-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression
(
- Contribution to journal › Article
- 2022
-
Mark
Ferroptosis in Parkinson's disease : glia–neuron crosstalk
(
- Contribution to journal › Scientific review
-
Mark
Brain region-specific microglial and astrocytic activation in response to systemic lipopolysaccharides exposure
(
- Contribution to journal › Article
-
Mark
Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation
(
- Contribution to journal › Article
- 2021
-
Mark
Postmortem Studies of Fetal Grafts in Parkinson’s Disease : What Lessons Have We Learned?
(
- Contribution to journal › Scientific review
-
Mark
FRET-Based Screening Identifies p38 MAPK and PKC Inhibition as Targets for Prevention of Seeded α-Synuclein Aggregation
(
- Contribution to journal › Article
-
Mark
Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
(
- Contribution to journal › Article
-
Mark
Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation
(
- Contribution to journal › Article
-
Mark
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
(
- Contribution to journal › Article